Russell Investments Group Ltd. Has $821,000 Stock Holdings in Relx Plc (NYSE:RELX)

Russell Investments Group Ltd. raised its holdings in shares of Relx Plc (NYSE:RELX - Free Report) by 38.0% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 18,066 shares of the technology company's stock after acquiring an additional 4,976 shares during the period. Russell Investments Group Ltd.'s holdings in Relx were worth $821,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in RELX. CENTRAL TRUST Co raised its position in shares of Relx by 1,290.2% during the 4th quarter. CENTRAL TRUST Co now owns 570 shares of the technology company's stock valued at $26,000 after acquiring an additional 529 shares during the last quarter. Versant Capital Management Inc bought a new stake in shares of Relx during the 4th quarter valued at $31,000. Sierra Ocean LLC bought a new stake in shares of Relx during the 4th quarter valued at $43,000. Brown Brothers Harriman & Co. raised its position in shares of Relx by 218.5% during the 4th quarter. Brown Brothers Harriman & Co. now owns 965 shares of the technology company's stock valued at $44,000 after acquiring an additional 662 shares during the last quarter. Finally, Private Trust Co. NA raised its position in shares of Relx by 19.2% during the 4th quarter. Private Trust Co. NA now owns 1,237 shares of the technology company's stock valued at $56,000 after acquiring an additional 199 shares during the last quarter. Institutional investors own 15.02% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms recently commented on RELX. The Goldman Sachs Group initiated coverage on shares of Relx in a research report on Wednesday, March 26th. They issued a "buy" rating for the company. Redburn Atlantic started coverage on Relx in a research note on Wednesday, January 8th. They issued a "buy" rating for the company. StockNews.com lowered Relx from a "buy" rating to a "hold" rating in a research report on Tuesday, March 4th. Morgan Stanley reaffirmed an "overweight" rating on shares of Relx in a research report on Wednesday, April 16th. Finally, Barclays raised Relx from an "equal weight" rating to an "overweight" rating in a research report on Friday, March 14th. One investment analyst has rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Buy".

Relx Stock Down 0.3 %

Shares of NYSE RELX traded down $0.18 during mid-day trading on Monday, reaching $53.37. 589,217 shares of the company's stock were exchanged, compared to its average volume of 709,219. The firm has a market capitalization of $98.78 billion, a price-to-earnings ratio of 28.69, a PEG ratio of 2.73 and a beta of 0.84. The company has a current ratio of 0.52, a quick ratio of 0.47 and a debt-to-equity ratio of 1.46. The business has a fifty day simple moving average of $49.59 and a 200 day simple moving average of $48.29. Relx Plc has a twelve month low of $40.77 and a twelve month high of $53.56.

Relx Increases Dividend

The company also recently announced a semi-annual dividend, which will be paid on Wednesday, June 25th. Investors of record on Friday, May 9th will be given a $0.5586 dividend. This represents a yield of 1.6%. The ex-dividend date is Friday, May 9th. This is a positive change from Relx's previous semi-annual dividend of $0.23. Relx's dividend payout ratio (DPR) is currently 59.68%.

Relx Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.